Dolagis Tablets for Dogs | 
Dolagis contain the drug carprofen, which is widely used in veterinary medicine to control pain and inflammation in dogs. It is most often used for osteo-arthritis or degenerative joint disease in older dogs, but can also be used for the treatment of injuries and post-operative discomfort too. Dolagis 50mg tablets and Dolagis 120mg tablets are available. Both sizes are conveniently scored so that they easily break into quarters.
| | | | |
| Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: Alstoe Ltd
Address: The Industrial Park
Sheriff Hutton
York
YO60 6RZ
Telephone: 01347 878606
Fax: 01347 878333
Email: info@alstoe.co.uk
Website: www.alstoe.co.uk
Presentation
Flavoured, beige coloured clover-shaped tablets scored to divide into four equal parts. Each tablet contains 50 mg of carprofen.
Uses
Dogs: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
Dosage and administration
Oral administration: 4 mg carprofen per kg bodyweight per day. An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours. The daily dose may be reduced, subject to clinical response. Duration of treatment will be dependant upon the response seen. Long term treatment should be under regular veterinary supervision.
To extend analgesic and anti-inflammatory cover post-operatively parenteral pre-operative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days.
Do not exceed the stated dose.
Contra-indications, warnings, etc
Do not use in cats, in pregnant and lactating bitches, in dogs aged less than 4 months in the absence of specific data, in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia. Do not use in case of hypersensitivity to the active substance, to other NSAIDs and to any of the excipients.
Use in dogs less than 6 weeks of age, or in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs (e.g. aminogylcoside antibiotics) should be avoided. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. As with other NSAIDs, photodermatitis during treatment with carprofen has been observed in laboratory animals and in humans. These skin reactions have never been observed in dogs. Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Do not use this drug concurrently with other NSAIDs or with glucocorticoids.
Pharmaceutical precautions
Do not store above 30°C. Protect from light.
Keep out of reach of children.
Divided tablets should be stored in the blister pack. Any divided tablet portions remaining after 72 hours should be discarded.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Legal category
POM-V
Packaging Quantities
Carton containing 10 blisters of 10 tablets.
Further information
Precautions to be taken by the person administering the product to animals: in case of accidental ingestion, seek medical advice immediately and show the package leaflet to the physician.
Marketing authorisation number
Vm 20749/4005.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Alstoe Ltd
Address: The Industrial Park
Sheriff Hutton
York
YO60 6RZ
Telephone: 01347 878606
Fax: 01347 878333
Email: info@alstoe.co.uk
Website: www.alstoe.co.uk
Presentation
Flavoured, beige coloured clover-shaped tablets scored to divide into four equal parts. Each tablet contains 50 mg of carprofen.
Uses
Dogs: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
Dosage and administration
Oral administration: 4 mg carprofen per kg bodyweight per day. An
initial dose of 4 mg carprofen per kg bodyweight per day given as a
single daily dose. The analgesic effect from each dose persists for at
least 12 hours. The daily dose may be reduced, subject to clinical
response. Duration of treatment will be dependant upon the response
seen. Long term treatment should be under regular veterinary
supervision.
To extend analgesic and anti-inflammatory cover post-operatively
parenteral pre-operative treatment with an injectable carprofen may be
followed with carprofen tablets at 4 mg/kg/day for 5 days.
Do not exceed the stated dose.
Contra-indications, warnings, etc
Do not use in cats, in pregnant and lactating bitches, in dogs aged less
than 4 months in the absence of specific data, in dogs, suffering from
cardiac, hepatic or renal disease, when there is a possibility of
gastrointestinal ulceration or bleeding or where there is evidence of
blood dyscrasia. Do not use in case of hypersensitivity to the active
substance, to other NSAIDs and to any of the excipients.
Use in dogs less than 6 weeks of age, or in aged dogs, may involve
additional risk. If such a use cannot be avoided, dogs may require a
reduced dosage and careful clinical management. Avoid use in any
dehydrated, hypovolaemic or hypotensive dog, as there is a potential
risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs (e.g.
aminogylcoside antibiotics) should be avoided. NSAIDs can cause
inhibition of phagocytosis and hence in the treatment of inflammatory
conditions associated with bacterial infection, appropriate concurrent
antimicrobial therapy should be instigated. As with other NSAIDs,
photodermatitis during treatment with carprofen has been observed in
laboratory animals and in humans. These skin reactions have never been
observed in dogs. Do not administer other NSAIDs concurrently or within
24 hours of each other. Some NSAIDs may be highly bound to plasma
proteins and compete with other highly bound drugs, which can lead to
toxic effects. Do not use this drug concurrently with other NSAIDs or
with glucocorticoids.
Pharmaceutical precautions
Do not store above 30°C. Protect from light.
Keep out of reach of children.
Divided tablets should be stored in the blister pack. Any divided tablet portions remaining after 72 hours should be discarded.
Any unused veterinary medicinal product or waste materials derived from
such veterinary medicinal products should be disposed of in accordance
with local requirements.
Legal category
POM-V
Packaging Quantities
Carton containing 10 blisters of 10 tablets.
Further information
Precautions to be taken by the person administering the product to
animals: in case of accidental ingestion, seek medical advice
immediately and show the package leaflet to the physician.
Marketing authorisation number
V m 20749/4005.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: Alstoe Ltd
Address: The Industrial Park
Sheriff Hutton
York
YO60 6RZ
Telephone: 01347 878606
Fax: 01347 878333
Email: info@alstoe.co.uk
Website: www.alstoe.co.uk
Presentation
Flavoured, beige coloured clover-shaped chewable tablets scored to divide into four equal parts. Each tablet contains 120 mg of carprofen.
Uses
Dogs: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
Dosage and administration
Oral administration: 4 mg carprofen per kg bodyweight per day. An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours. The daily dose may be reduced, subject to clinical response. Duration of treatment will be dependant upon the response seen. Long term treatment should be under regular veterinary supervision.
To extend analgesic and anti-inflammatory cover post-operatively parenteral pre-operative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days.
Do not exceed the stated dose.
Contra-indications, warnings, etc
Do not use in cats, in pregnant and lactating bitches, in dogs aged less than 4 months in the absence of specific data, in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia. Do not use in case of hypersensitivity to the active substance, to other NSAIDs and to any of the excipients.
Use in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs (e.g. aminogylcoside antibiotics) should be avoided. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. As with other NSAIDs, photodermatitis during treatment with carprofen has been observed in laboratory animals and in humans. These skin reactions have never been observed in dogs. Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Do not use this drug concurrently with other NSAIDs or with glucocorticoids.
Pharmaceutical precautions
Do not store above 30°C. Protect from light.
Divided tablets should be stored in the blister pack. Any divided tablet portions remaining after 72 hours should be discarded.
Keep out of reach of children.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Legal category
POM-V
Packaging Quantities
Carton containing 20 blisters of 6 tablets.
Further information
Precautions to be taken by the person administering the product to animals: in case of accidental ingestion, seek medical advice immediately and show the package leaflet to the physician.
Marketing authorisation number
Vm 20749/4017.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Alstoe Ltd
Address: The Industrial Park
Sheriff Hutton
York
YO60 6RZ
Telephone: 01347 878606
Fax: 01347 878333
Email: info@alstoe.co.uk
Website: www.alstoe.co.uk
Presentation
Flavoured, beige coloured clover-shaped chewable tablets scored to divide into four equal parts. Each tablet contains 120 mg of carprofen.
Uses
Dogs: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
Dosage and administration
Oral administration: 4 mg carprofen per kg bodyweight per day. An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours. The daily dose may be reduced, subject to clinical response. Duration of treatment will be dependant upon the response seen. Long term treatment should be under regular veterinary supervision.
To extend analgesic and anti-inflammatory cover post-operatively parenteral pre-operative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days.
Do not exceed the stated dose.
Contra-indications, warnings, etc
Do not use in cats, in pregnant and lactating bitches, in dogs aged less than 4 months in the absence of specific data, in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia. Do not use in case of hypersensitivity to the active substance, to other NSAIDs and to any of the excipients.
Use in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs (e.g. aminogylcoside antibiotics) should be avoided. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. As with other NSAIDs, photodermatitis during treatment with carprofen has been observed in laboratory animals and in humans. These skin reactions have never been observed in dogs. Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Do not use this drug concurrently with other NSAIDs or with glucocorticoids.
Pharmaceutical precautions
Do not store above 30°C. Protect from light.
Divided tablets should be stored in the blister pack. Any divided tablet portions remaining after 72 hours should be discarded.
Keep out of reach of children.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Legal category
POM-V
Packaging Quantities
Carton containing 20 blisters of 6 tablets.
Further information
Precautions to be taken by the person administering the product to animals: in case of accidental ingestion, seek medical advice immediately and show the package leaflet to the physician.
Marketing authorisation number
Vm 20749/4017.
| 
